Pharmalot... Pharmalittle... Good Morning

Good morning, everyone, and welcome to another working week. We hope the weekend was relaxing, despite the crush of news coming from the big oncology meeting, which dominates the menu of tidbits seen below. As always, we are coping with the return of meetings and deadlines by fortifying ourselves with a cup or three of stimulation and invite you to join us. Our flavor today, by the way, is French Toast. And now, on to the next big thing. Hope your day goes well and do stay in touch... Merck Melanoma Drug Shrinks Tumors In 38 Percent Of Patients: Study (Reuters) Vinegar Test For Cervical Cancer Reduced Mortality Rates (Pharma Times) USP Delays Deadlines For Complying With Impurity Standards (InPharma Technologist) Draft Regs OKed For EU Clinical Trial Data Transparency (Outsourcing Pharma) Sanofi Ends Research Into A Pair Of Cancer Drugs (Bloomberg News) Depomed Abandons Menopause Drug After FDA Rejection (Associated Press) Roche's Avastin Fails In Brain Cancer; Helps In Cervical Cancer (Bloomberg News) Teva Gets EU Backing For...Read more
Source: Pharmalot - Category: Pharma Commentators Authors: Source Type: blogs